Despite being unable to declare statistical success, the company claimed its therapy showed enough promise to support moving ...
Clascoterone 5%, a topical anti-androgen drug indicated for male pattern hair loss, demonstrated significant hair regrowth ...
Dr. Hordinsky discusses how clascoterone 5% topical solution may reshape male AGA management and expand treatment confidence.
Nektar Therapeutics stock is trading lower Monday afternoon as the market continues to assess mixed topline results from the ...
Nektar Therapeutics is planning to bring its interleukin-2-targeting drug candidate into a phase 3 trial for severe alopecia ...
Patients with alopecia areata are at a greater risk for psychiatric disorders than control patients, including depression and anxiety, among others.
Byrdie on MSN
You're not the only one dealing with hair thinning at the temples—experts explain why it's so common
Hair thinning at the temples is often due to genetics, specifically a condition known as androgenetic alopecia. Health conditions, vitamin deficiency, and some lifestyle choices, like wearing tight ...
Nektar Therapeutics reported Phase 2b alopecia areata data showing hair regrowth trends, narrowly missing significance before ...
Despite falling short of its primary Phase II objective, Nektar plans to push its T cell stimulator rezpeg into Phase III ...
Here are the top 5 most-viewed alopecia content in 2025.
Back in October, the 2025 Fall Clinical Dermatology Conference showcased some of the most exciting advances in skin disease treatment this year. From pill-based TYK2 inhibitors and durable IL-23 ...
Jada Pinkett Smith interviewed the mom on "Red Table Talk." She said her late daughter's classmates would call her names and smack her head.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback